SCM Lifescience Statistics

Total Valuation

SCM Lifescience has a market cap or net worth of KRW 23.41 billion. The enterprise value is 29.46 billion.

Market Cap	23.41B
Enterprise Value	29.46B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SCM Lifescience has 20.47 million shares outstanding. The number of shares has increased by 37.71% in one year.

Current Share Class	n/a
Shares Outstanding	20.47M
Shares Change (YoY)	+37.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.03%
Owned by Institutions (%)	n/a
Float	16.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.38
PB Ratio	1.65
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.38
EV / Sales	35.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.09

Financial Position

The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.49.

Current Ratio	0.35
Quick Ratio	0.18
Debt / Equity	0.49
Debt / EBITDA	n/a
Debt / FCF	-0.49
Interest Coverage	-43.50

Financial Efficiency

Return on equity (ROE) is -71.44% and return on invested capital (ROIC) is -31.11%.

Return on Equity (ROE)	-71.44%
Return on Assets (ROA)	-29.10%
Return on Invested Capital (ROIC)	-31.11%
Return on Capital Employed (ROCE)	-64.88%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	1.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.22% in the last 52 weeks. The beta is 1.12, so SCM Lifescience's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	-62.22%
50-Day Moving Average	1,341.46
200-Day Moving Average	2,014.79
Relative Strength Index (RSI)	45.64
Average Volume (20 Days)	943,128

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCM Lifescience had revenue of KRW 824.80 million and -12.38 billion in losses. Loss per share was -605.00.

Revenue	824.80M
Gross Profit	313.05M
Operating Income	-11.31B
Pretax Income	-13.04B
Net Income	-12.38B
EBITDA	-10.45B
EBIT	-11.31B
Loss Per Share	-605.00

Full Income Statement

Balance Sheet

The company has 919.76 million in cash and 6.97 billion in debt, giving a net cash position of -6.05 billion or -295.43 per share.

Cash & Cash Equivalents	919.76M
Total Debt	6.97B
Net Cash	-6.05B
Net Cash Per Share	-295.43
Equity (Book Value)	14.18B
Book Value Per Share	694.02
Working Capital	-3.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.05 billion and capital expenditures -4.07 billion, giving a free cash flow of -14.13 billion.

Operating Cash Flow	-10.05B
Capital Expenditures	-4.07B
Free Cash Flow	-14.13B
FCF Per Share	-690.21

Full Cash Flow Statement

Margins

Gross Margin	37.95%
Operating Margin	-1,370.97%
Pretax Margin	-1,580.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCM Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.71%
Shareholder Yield	-37.71%
Earnings Yield	-52.86%
FCF Yield	-60.33%

Stock Splits

The last stock split was on September 15, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 15, 2023
Split Type	Forward
Split Ratio	1.2

Scores

SCM Lifescience has an Altman Z-Score of -9.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.35
Piotroski F-Score	n/a